These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 8570772

  • 1. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
    Meltzer HY, Maes M.
    Psychiatry Res; 1995 Sep 29; 58(2):89-98. PubMed ID: 8570772
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb 29; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.
    Sevy S, Brown SL, Wetzler S, Kotler M, Molcho A, Plutchik R, van Praag HM.
    Psychiatry Res; 1994 Sep 29; 53(3):219-29. PubMed ID: 7870844
    [Abstract] [Full Text] [Related]

  • 8. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM, Cunningham KA.
    Eur J Pharmacol; 1994 May 12; 257(1-2):27-38. PubMed ID: 8082704
    [Abstract] [Full Text] [Related]

  • 9. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 May 12; 119(2):222-30. PubMed ID: 7659770
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists.
    Lesch KP, Söhnle K, Poten B, Schoellnhammer G, Rupprecht R, Schulte HM.
    J Clin Endocrinol Metab; 1990 Mar 12; 70(3):670-4. PubMed ID: 1968468
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.
    Gibson EL, Barnfield AM, Curzon G.
    Neuropharmacology; 1994 Mar 12; 33(3-4):457-65. PubMed ID: 7984284
    [Abstract] [Full Text] [Related]

  • 14. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS, Westenberg HG.
    J Psychiatr Res; 2008 Sep 12; 42(11):894-901. PubMed ID: 18533183
    [Abstract] [Full Text] [Related]

  • 15. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL, Meltzer HY.
    J Pharmacol Exp Ther; 1997 Aug 12; 282(2):699-706. PubMed ID: 9262333
    [Abstract] [Full Text] [Related]

  • 16. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
    Yamada J, Sugimoto Y.
    Eur J Pharmacol; 2000 Oct 06; 406(1):153-7. PubMed ID: 11011047
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test.
    Leone M, Attanasio A, Croci D, Ferraris A, D'Amico D, Grazzi L, Nespolo A, Bussone G.
    Neuroreport; 1998 Aug 03; 9(11):2605-8. PubMed ID: 9721941
    [Abstract] [Full Text] [Related]

  • 19. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D, Helsley S, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Dec 03; 122(3):237-43. PubMed ID: 8748393
    [Abstract] [Full Text] [Related]

  • 20. Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man.
    Palazidou E, Stephenson J, Butler J, Coskeran P, Chambers S, McGregor AM.
    Psychopharmacology (Berl); 1995 Jun 03; 119(3):311-4. PubMed ID: 7675967
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.